{"transactions":[{"id":929845,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-27T22:04:42.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":153822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":153822,"derivative":{"exercise_price":3.6,"expiration_date":"2036-01-26","underlying":"Common Stock","underlying_shares":153822},"source":{"system":"sec-edgar","filing":"0001193125-26-024833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526024833/ownership.xml","form_type":"4"}},{"id":929844,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-27T22:04:42.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":25637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":76443,"source":{"system":"sec-edgar","filing":"0001193125-26-024833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526024833/ownership.xml","form_type":"4"}},{"id":1295387,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T21:16:59.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":139838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":139838,"derivative":{"exercise_price":3.46,"expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":139838},"source":{"system":"sec-edgar","filing":"0001062993-25-001080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299325001080/form4.xml","form_type":"4"}},{"id":1295386,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-01-24T21:16:59.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":23306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":50806,"source":{"system":"sec-edgar","filing":"0001062993-25-001080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299325001080/form4.xml","form_type":"4"}},{"id":1675014,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T21:33:33.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on January 17, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":135000,"derivative":{"exercise_price":4.21,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001062993-24-001086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299324001086/form4.xml","form_type":"4"}},{"id":1675013,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-01-19T21:33:33.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":27500,"source":{"system":"sec-edgar","filing":"0001062993-24-001086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299324001086/form4.xml","form_type":"4"}},{"id":1717570,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-12-08T21:08:38.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.7323,"value":18661.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.768, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001062993-23-022200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299323022200/form4.xml","form_type":"4"}},{"id":2024415,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68692,"kind":"person","name":"Shankar Gopi","position":1,"cik":"0001965014","reported_name":"Shankar Gopi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-09T22:06:58.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on February 7, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":180000,"derivative":{"exercise_price":5.88,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000899243-23-004438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924323004438/doc4.xml","form_type":"4"}}]}